One of the most common malfunctions of the human body is an excess of copper and deficiency of zinc (copper-zinc imbalance), which can lead to a myriad of issues.
A new report shows that findings from clinical studies used to gain FDA approval of antidepressants aren't applicable to most patients with depression.
A recent study showed that mindfulness-based cognitive therapy is more effective than antidepressants for treating depression.
Pregnant moms taking Prozac give birth to 4x as many babies with heart problems; new study shows low cholesterol increases risk of suicide.
This week's article in my continuing series on antidepressants will examine the physiological, psychological and social consequences of antidepressant use.
Contrary to what pharmaceutical advertising and popular belief suggests, there is no scientific evidence supporting the idea that depression is caused by a chemical imbalance.
Antidepressants have been shown to be no more effective than placebos. But do they have any place at all in the treatment of depression?
Drug companies make $285 billion a year selling their products. Can we trust them to provide doctors, researchers and patients with reliable information? Continue reading for the full story.
Recent studies on the efficacy of antidepressant drugs revealed that selective serotonin reuptake inhibitors (SSRIs), which are the most commonly prescribed drugs to treat depression, have no clinically meaningful advantage over placebo.